Skip to main content
. Author manuscript; available in PMC: 2018 Jan 25.
Published in final edited form as: J Intern Med. 2014 Oct;276(4):352–363. doi: 10.1111/joim.12244

Table 1.

SGLT2 inhibitors under development

Drug Stage Reference
Dapagliflozin Approved In Europe 27
Canagliflozin Approved by FDA 38
Ipragliflozin Phase III 47
Empagliflozin Phase III 43
LX4211 Phase II 49
PF04791729 Phase II 51
TS-071 Phase II 50